These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 10735695)
1. Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting. Bidstrup BP; Hunt BJ; Sheikh S; Parratt RN; Bidstrup JM; Sapsford RN Ann Thorac Surg; 2000 Feb; 69(2):541-7. PubMed ID: 10735695 [TBL] [Abstract][Full Text] [Related]
2. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients. Bernet F; Carrel T; Marbet G; Skarvan K; Stulz P J Card Surg; 1999; 14(2):92-7. PubMed ID: 10709819 [TBL] [Abstract][Full Text] [Related]
3. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. Alvarez JM; Jackson LR; Chatwin C; Smolich JJ J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294 [TBL] [Abstract][Full Text] [Related]
4. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345 [TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
6. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. Casas JI; Zuazu-Jausoro I; Mateo J; Oliver A; Litvan H; Muñiz-Díaz E; Arís A; Caralps JM; Fontcuberta J J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1107-17. PubMed ID: 7475139 [TBL] [Abstract][Full Text] [Related]
7. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin. Klein M; Keith PR; Dauben HP; Schulte HD; Beckmann H; Mayer G; Elert O; Gams E Eur J Cardiothorac Surg; 1998 Oct; 14(4):360-6. PubMed ID: 9845139 [TBL] [Abstract][Full Text] [Related]
9. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery. Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564 [TBL] [Abstract][Full Text] [Related]
10. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group. Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145 [TBL] [Abstract][Full Text] [Related]
11. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162 [TBL] [Abstract][Full Text] [Related]
12. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267 [TBL] [Abstract][Full Text] [Related]
13. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
14. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046 [TBL] [Abstract][Full Text] [Related]